Infectious Diseases (except HIV/AIDS)
Showing page 586 of 716 pages of list content
-
Heterogeneity in risk, testing and outcome of COVID-19 across outbreak settings in the Greater Toronto Area, Canada: an observational study
This article's authors -
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
This article's authors -
Significance of SARS-CoV-2 Specific Antibody Testing during COVID-19 Vaccine Allocation
This article's authors -
COVID-19: Modelling Local Transmission and Morbidity effects to provide an estimate of overall Relative Healthcare Resource Impact by General Practice Granularity
This article's authors -
Early Clinical Factors Predicting the Development of Critical Disease in Japanese Patients with COVID-19: A Single-Center Retrospective, Observational Study
This article's authors -
Serological prevalence of antibodies to SARS CoV-2 amongst cancer centre staff
This article's authors -
LamPORE: rapid, accurate and highly scalable molecular screening for SARS-CoV-2 infection, based on nanopore sequencing
This article's authors -
From more testing to smart testing: data-guided SARS-CoV-2 testing choices
This article's authors -
Clinical and historical features associated with severe COVID-19 infection: a systematic review
This article's authors -
Mitochondrial induced T cell apoptosis and aberrant myeloid metabolic programs define distinct immune cell subsets during acute and recovered SARS-CoV-2 infection
This article's authors